20.06
price up icon2.40%   0.47
after-market Dopo l'orario di chiusura: 20.05 -0.010 -0.05%
loading
Precedente Chiudi:
$19.59
Aprire:
$19.61
Volume 24 ore:
192.12K
Relative Volume:
0.98
Capitalizzazione di mercato:
$358.52M
Reddito:
$116.88M
Utile/perdita netta:
$-25.09M
Rapporto P/E:
-143.29
EPS:
-0.14
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+6.14%
1M Prestazione:
+5.97%
6M Prestazione:
-8.02%
1 anno Prestazione:
+98.42%
Intervallo 1D:
Value
$19.43
$20.29
Intervallo di 1 settimana:
Value
$18.66
$20.29
Portata 52W:
Value
$8.61
$29.82

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
Nome
Rigel Pharmaceuticals
Name
Telefono
650-624-1100
Name
Indirizzo
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
Dipendente
164
Name
Cinguettio
@rigelpharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
RIGL's Discussions on Twitter

Confronta RIGL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RIGL
Rigel Pharmaceuticals
20.06 337.79M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-04-03 Ripresa Piper Sandler Neutral
2022-06-09 Downgrade Citigroup Buy → Neutral
2022-06-08 Downgrade Cantor Fitzgerald Overweight → Neutral
2022-06-08 Downgrade Piper Sandler Overweight → Neutral
2022-03-23 Iniziato B. Riley Securities Neutral
2020-11-09 Downgrade JP Morgan Overweight → Neutral
2019-11-15 Ripresa Cantor Fitzgerald Overweight
2019-09-26 Ripresa JP Morgan Overweight
2019-03-01 Reiterato Cantor Fitzgerald Overweight
2018-08-27 Iniziato Citigroup Buy
2018-05-02 Reiterato Cantor Fitzgerald Overweight
2017-12-21 Ripresa Piper Jaffray Overweight
2017-12-15 Iniziato Cantor Fitzgerald Overweight
2017-11-06 Ripresa H.C. Wainwright Buy
2017-03-09 Reiterato H.C. Wainwright Buy
2016-08-31 Reiterato H.C. Wainwright Buy
2016-08-30 Reiterato Piper Jaffray Overweight
2016-07-13 Iniziato H.C. Wainwright Buy
2016-06-13 Iniziato Piper Jaffray Overweight
2016-04-22 Aggiornamento JP Morgan Neutral → Overweight
2013-04-08 Reiterato Stifel Buy
2012-11-29 Iniziato UBS Neutral
2012-11-06 Reiterato Oppenheimer Outperform
2012-03-26 Iniziato Canaccord Genuity Hold
2010-12-10 Downgrade MP Advisors Outperform → Market Perform
Mostra tutto

Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie

pulisher
Jul 22, 2025

What analysts say about Rigel Pharmaceuticals Inc. stockHigh-impact stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Rigel Pharmaceuticals Inc. a good long term investmentOutstanding yields - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

(RIGL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Rigel Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Rigel Pharmaceuticals Inc. stock priceTriple-digit returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 15, 2025

What makes Rigel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

Why Rigel Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Insider Monkey

Jul 10, 2025
pulisher
Jul 10, 2025

(RIGL) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | RIGL Stock News - GuruFocus

Jul 07, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛

Jul 07, 2025
pulisher
Jun 18, 2025

Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Canada

Jun 14, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com

Jun 14, 2025
pulisher
Jun 11, 2025

High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Rigel Pharma To Present At Jefferies Global Healthcare Conference; Webcast At 12:50 PM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Rigel to Present at the Jefferies Global Healthcare Conference - StreetInsider

May 29, 2025
pulisher
May 28, 2025

Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference – Company Announcement - Financial Times

May 28, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India

May 26, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com

May 26, 2025
pulisher
May 25, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World

May 25, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks

May 23, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

May 22, 2025
pulisher
May 22, 2025

Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 22, 2025

Rigel Pharmaceuticals Azioni (RIGL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Capitalizzazione:     |  Volume (24 ore):